Pulmonary Manifestations of Systemic Disease |

Pulmonary Function Tests in HIV Patients: Significance of High Viral Load FREE TO VIEW

Navitha Ramesh, MD; Marjan Islam, MD; Jason Filopei, MD; Kartik Ramakrishna, MD; Mary Harris, MD; Albert Miller, MD
Author and Funding Information

Mount Sinai Beth Israel, Chesterfield, NJ

Chest. 2015;148(4_MeetingAbstracts):865A. doi:10.1378/chest.2273828
Text Size: A A A
Published online


SESSION TITLE: Pulmonary Manifestations of Systemic Disease Posters

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 28, 2015 at 01:30 PM - 02:30 PM

PURPOSE: To look for an association between both viral load and CD4 cell count and Pulmonary Function Tests (PFTs) in patients infected with HIV.

METHODS: Design: Retrospective analysis. Setting: Academic, Community hospital HIV-AIDS clinic and PFT laboratory. Subjects: Patients infected with HIV, over the age of 18 who have had PFTs performed within a year of their CD4 and viral load testing. Demographic data, PFT data, CD4 counts, viral load levels, hemoglobin and smoking status were obtained. Patients were analyzed in 2 groups based on CD4 cell count (CD4<200 cells/mm3 and CD4>200 cells/mm3) and two groups based on viral load (VL<75 copies/ml and VL >75 copies/ml).

RESULTS: Out of 932 patients being followed at a HIV clinic, 108 had PFTs performed. Fifty six percent were male. The mean age was 53.4 years. The population was 48% Hispanic, 32% African American, 19% Caucasian and 1% Asian. PFTs in patients with high VL (> 75 copies/ml) compared to low VL (<75 copies/ml) were associated with a significantly decreased diffusing capacity (DLCO) (61% vs 70%; p=0.04) and significantly decreased total lung capacity (TLC) (77% vs 89%; p= 0.04). FEV1/FVC was significantly higher in those with a CD4 count <200 cells/mm3 (77% vs 70%; p<0.01), despite the significantly higher number of smokers in this group (52% vs 22%, p=<0.01). There was no significant association between CD4 count and DLCO or TLC.

CONCLUSIONS: The DLCO and TLC are decreased significantly in HIV patients with high viral load. Our data would indicate parenchymal involvement in these patients, which correlates significantly with viral load, but not with the CD4 count. This could explain the crucial role played by the virus itself in the pathogenesis of pulmonary disease in HIV.

CLINICAL IMPLICATIONS: Patients with HIV with inadequate suppression of viral load may be at a higher risk of pulmonary interstitial disease and pulmonary vascular disease. We recommend assessment of DLCO in addition to spirometry in these patients. Abormal findings could be studied further using CT imaging, pathology findings abd radionucleotide uptake studies.

DISCLOSURE: The following authors have nothing to disclose: Navitha Ramesh, Marjan Islam, Jason Filopei, Kartik Ramakrishna, Mary Harris, Albert Miller

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
The Pulmonary Effects of Long-term Exposure to Aerosol Pentamidine*: A 5-Year Surveillance Study in HIV-Infected Patients
PubMed Articles
Personality disorders in patients with HIV/AIDS.
New York State Department of Health | 7/20/2006
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543